Loci Orthopaedics Ltd.

Daniel O’Mahony is a Partner at Seroba Life Sciences venture capital fund and brings a wealth of experience from pharma and medtech industry in product development, clinical trials, product commercialisation, strategic planning, licensing, corporate venturing, technology commercialisation and venture capital investment. He held senior appointments at Elan Corporation plc from 1994-2003, where he was involved in technology and product development and in corporate venturing. He established the Technology Transfer Office at NUI Galway in 2005. Daniel graduated with a Ph.D. from University College Cork, holds a business degree in technology management from the Smurfit Business School, University College Dublin and has held academic appointments in Ireland and USA. He currently sits on a number of boards including Perfuze, Loci Orthopaedics, Carballo Group Limited and ATXA Therapeutics. He previously sat on the boards of PQ Bypass (acquired by Endologix), Novate Medical (acquired by BTG), Apica Cardiovascular (acquired by Thoratec), Covagen (acquired by Cilag/Janssen Pharmaceutical Companies of the Johnson & Johnson Group), Atlantic Therapeutics (acquired by Caldera Medical inc), Stokes Bio (acquired by Life Technologies), Straatum (acquired by Lam Research Corporation). Seroba is currently investing from its new fund, Fund IV with a focus in pharma /biotech and medtech investments. He has published in several scientific journals and is co-inventor on numerous patent families.

From the manufacturer's own website. Source